 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 679 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma (HBO) |
 |
Great Neck & Commack, NY USA |
 |
06/02/2010 |
 |
 |
 |
 |
 |
Details |
 |
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma |
 |
Great Neck & Commack, NY USA |
 |
06/02/2010 |
 |
 |
 |
Details |
 |
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. |
 |
Rochester, NY USA |
 |
04/13/2010 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Houston, TX USA |
 |
03/30/2010 |
 |
 |
 |
Details |
 |
2009-0476: A Phase I dose-finding study of XL184 administered orally in combination with Temozolomide and Radiation Therapy in first line treatment of glioblastoma |
 |
Houston, TX USA |
 |
03/30/2010 |
 |
 |
 |
 |
 |
Details |
 |
2008-0318: Phase I/II trial of Dasatinib (Sprycel) with Radiation Therapy and concomitant and Adjuvant Temozolomide in Patients with newly diagnosed Glioblastoma |
 |
Houston, TX USA |
 |
03/29/2010 |
 |
 |
 |
Details |
 |
2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
 |
Houston, TX USA |
 |
03/29/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Detroit, MI USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Durham, NC USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Charlottesville, VA USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Cleveland, OH USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Cleveland, OH USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Hackensack, NJ USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Syracuse, NY USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Chicago, IL USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Boston, MA USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Jacksonville, FL USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
New Haven, CT USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Buffalo, NY USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Salt Lake City, UT USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Columbus, OH USA |
 |
03/09/2010 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Evanston, IL USA |
 |
03/09/2010 |
 |
 |
 |
 |
 |